Mycobacterium abscessus - an uncommon, but important cause of peritoneal dialysis-associated peritonitis - case report and literature review.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
17 11 2020
Historique:
received: 27 07 2020
accepted: 02 11 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 3 11 2021
Statut: epublish

Résumé

Peritoneal dialysis (PD) is a form of therapy for end-stage kidney disease (ESKD), and peritonitis is a known complication. Mycobacterium (M) species associated peritonitis in PD patients is uncommon. Our experience of managing PD associated peritonitis caused by M abscessus in a middle-aged man with ESKD due to focal segmental glomerulosclerosis is shared in this article with a review of the literature on this condition. A 49-year old man presented to our unit with symptoms of peritonitis and cloudy PD effluent. Initial analysis of PD fluid showed Gram stain was negative, with no organism grown. Empirical PD peritonitis treatment with intra-peritoneal antibiotics did not improve his symptoms and he required intravenous antibiotics, PD catheter removal and a switch to haemodialysis. Cultures of the PD fluid later grew M abscessus, and the antibiotic regimen was changed appropriately, leading to clinical improvement. M abscessus associated peritonitis in PD patients is rare. It needs to be borne in mind when clinical improvement is not seen with standard broad-spectrum antibiotics, especially in situations where the PD fluid is initially deemed to be culture negative. PD fluid samples should be sent for acid-fast bacillus and if detected, should be further analysed with genome-wide sequencing to confirm the species of the Mycobacterium. Prompt removal of the catheter with peritoneal washout is critical for clinical improvement.

Sections du résumé

BACKGROUND
Peritoneal dialysis (PD) is a form of therapy for end-stage kidney disease (ESKD), and peritonitis is a known complication. Mycobacterium (M) species associated peritonitis in PD patients is uncommon. Our experience of managing PD associated peritonitis caused by M abscessus in a middle-aged man with ESKD due to focal segmental glomerulosclerosis is shared in this article with a review of the literature on this condition.
CASE PRESENTATION
A 49-year old man presented to our unit with symptoms of peritonitis and cloudy PD effluent. Initial analysis of PD fluid showed Gram stain was negative, with no organism grown. Empirical PD peritonitis treatment with intra-peritoneal antibiotics did not improve his symptoms and he required intravenous antibiotics, PD catheter removal and a switch to haemodialysis. Cultures of the PD fluid later grew M abscessus, and the antibiotic regimen was changed appropriately, leading to clinical improvement.
CONCLUSION
M abscessus associated peritonitis in PD patients is rare. It needs to be borne in mind when clinical improvement is not seen with standard broad-spectrum antibiotics, especially in situations where the PD fluid is initially deemed to be culture negative. PD fluid samples should be sent for acid-fast bacillus and if detected, should be further analysed with genome-wide sequencing to confirm the species of the Mycobacterium. Prompt removal of the catheter with peritoneal washout is critical for clinical improvement.

Identifiants

pubmed: 33203375
doi: 10.1186/s12882-020-02146-4
pii: 10.1186/s12882-020-02146-4
pmc: PMC7672848
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

491

Références

J Antimicrob Chemother. 2012 Apr;67(4):810-8
pubmed: 22290346
J Clin Microbiol. 2013 Jan;51(1):217-23
pubmed: 23135941
Ren Fail. 2003 Sep;25(5):819-27
pubmed: 14575289
Saudi J Kidney Dis Transpl. 2012 Mar;23(2):321-4
pubmed: 22382227
Perit Dial Int. 2013 May-Jun;33(3):267-72
pubmed: 23032088
J Epidemiol Glob Health. 2016 Dec;6(4):243-248
pubmed: 27443487
J Formos Med Assoc. 2006 May;105(5):370-6
pubmed: 16638646
Nephrology (Carlton). 2011 Feb;16(2):174-9
pubmed: 21272129
BMC Nephrol. 2018 Nov 29;19(1):341
pubmed: 30497395
Am J Transplant. 2013 Aug;13(8):2137-45
pubmed: 23710593
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416
pubmed: 17277290
J Clin Tuberc Other Mycobact Dis. 2016 May 25;4:33-43
pubmed: 31723686
J Clin Microbiol. 2011 Apr;49(4):1421-5
pubmed: 21289148
Perit Dial Int. 2016 9-10;36(5):481-508
pubmed: 27282851
Nephrol Dial Transplant. 2012 Apr;27(4):1639-44
pubmed: 21891775
IDCases. 2017 May 04;9:6-7
pubmed: 28529886
Clin Lab Sci. 1998 Jul-Aug;11(4):206-8
pubmed: 10182108
Int Urol Nephrol. 2013 Aug;45(4):1129-35
pubmed: 23143752
Clin J Am Soc Nephrol. 2008 Sep;3(5):1526-33
pubmed: 18701615
Ther Apher Dial. 2007 Dec;11(6):449-51
pubmed: 18028172
Lancet Infect Dis. 2013 Feb;13(2):166-74
pubmed: 23347634
Am J Kidney Dis. 2018 Jun;71(6):814-821
pubmed: 29289475
Int Urol Nephrol. 2013 Oct;45(5):1423-8
pubmed: 23180442
Perit Dial Int. 2015 May-Jun;35(3):369-71
pubmed: 26015424
Clin Microbiol Infect. 2012 Mar;18(3):246-52
pubmed: 21631640
J Clin Microbiol. 2005 Sep;43(9):4357-62
pubmed: 16145077

Auteurs

Anup Singh Jheeta (AS)

South West Thames Renal & Transplantation Unit, Epsom & St Helier University Hospitals NHS Trust, Wrythe Lane, Carshalton, Surrey, SM5 1AA, UK.

Jayakeerthi Rangaiah (J)

Department of Microbiology, Epsom & St Helier University Hospitals NHS Trust, Wrythe Lane, Carshalton, Surrey, SM5 1AA, UK.

John Clark (J)

Department of Microbiology, Epsom & St Helier University Hospitals NHS Trust, Wrythe Lane, Carshalton, Surrey, SM5 1AA, UK.

David Makanjuola (D)

South West Thames Renal & Transplantation Unit, Epsom & St Helier University Hospitals NHS Trust, Wrythe Lane, Carshalton, Surrey, SM5 1AA, UK.

Subash Somalanka (S)

South West Thames Renal & Transplantation Unit, Epsom & St Helier University Hospitals NHS Trust, Wrythe Lane, Carshalton, Surrey, SM5 1AA, UK. Nephr0nite@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH